USPTO serial 76079653
GENERE NOSTRI FIDAMUS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 8, 2003
- Examiner
- FRYE, KIMBERLY
- Law office
- SCANNING ON DEMAND
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with GENERE NOSTRI FIDAMUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Gelsus Research & Consulting, Inc.
New York, NY
Other trademarks owned by Gelsus Research & Consulting, Inc.
Gelsus Research & Consulting, Inc.
New York, NY
Other trademarks owned by Gelsus Research & Consulting, Inc.
Gelsus Research & Consulting, Inc.
New York, NY
Other trademarks owned by Gelsus Research & Consulting, Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
ANNE KORNBAU
ANNE KORNBAU BROWDY AND NEIMARK624 NINTH ST NW STE 300WASHINGTON, DC 20001UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Pharmaceutical research and consulting services related to clinical studies and trials, namely, study monitoring of phases I-IV such as site selection, investigator recruitment, CRA and regional CRS recruitment, and status and enrollment; clinical data management and analysis, namely, case report form design, database design, protocol design, clinical plan development, and statistical support and analysis; conducting safety evaluations and reports, namely, statistically analyzing data obtained from clinical trials and adverse event reports and preparing reports regarding conclusions reached; preparing reports pursuant to Centre Internationale Office de Medicale Surveillence criteria and Food and Drug Administration regulatory affairs such as IND/NDA preparation; serving as a liaison to regulatory agencies regarding clinical studies; technical medical writing for physicians and scientists in the area of obesity, gasteroenterology, allergy endocrinology, internal medicine and hypertension; expert witness services in the fields of clinical pharmacy and clinical pharmacology | SECTION 8 - CANCELLED | Mar 1, 1997 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Gelsus Research & Consulting, Inc.
- Other trademarks owned by Gelsus Research & Consulting, Inc.
- Other trademarks owned by Gelsus Research & Consulting, Inc.
- Other trademarks in Class 042
- Similar marks named GENERE NOSTRI FIDAMUS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 14, 2009 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 9, 2008 | CFIT | CASE FILE IN TICRS | — |
| Apr 8, 2003 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 14, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 25, 2002 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 17, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 29, 2002 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Oct 25, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 24, 2001 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 11, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 2, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 21, 2000 | DOCK | ASSIGNED TO EXAMINER | — |